Cutaneous Necrotizing Venulitis
Cutaneous necrotizing venulitis (CNV), also called cutaneous leukocytoclastic vasculitis (LCV), is a small-vessel vasculitis that damages the post-capillary venules of the superficial and deep dermis. It is driven by a type III (immune complex) hypersensitivity reaction, which leads to fibrinoid necrosis of the vessel wall, leakage of red blood cells and infiltration by fragmenting neutrophils (leukocytoclasia). Although most cases of CNV are confined to the skin, it can also be the first sign of an underlying systemic disease (such as systemic lupus erythematosus, rheumatoid arthritis, ANCA-associated vasculitis, chronic infection or a drug reaction). At Haute-Derma, we follow a rigorous workup to distinguish skin-limited from systemic vasculitis, combining medical treatment that brings the acute phase under control with restorative therapy to prevent necrotic scarring.
The cellular and immunological mechanisms are as follows:
- Immune complex deposition (type III hypersensitivity):
- Circulating antigens (from drugs, bacteria, viruses or the body's own tissues) bind to antibodies (IgG, IgM, IgA) to form circulating immune complexes.
- Because blood flow is slow and hydrostatic pressure is high in the post-capillary venules (especially in the lower third of the legs), these immune complexes become trapped in the vessel walls.
- Complement activation and neutrophil infiltration:
- The deposited immune complexes activate the classical complement pathway, releasing the anaphylatoxins C3a and C5a. C5a is a powerful chemotactic factor that recruits large numbers of neutrophils, which stick to the endothelial cells.
- The neutrophils release lysosomal enzymes, reactive oxygen species (ROS) and myeloperoxidase, which damage and break down the vessel wall.
- Fibrinoid necrosis, vessel occlusion and increased permeability:
- Destruction of the endothelium leads to fibrinoid necrosis of the vessel wall, allowing red blood cells to escape into the dermis (producing purpura that does not blanch on pressure – palpable purpura).
- The neutrophils break apart, leaving fragments of degenerated nuclei (leukocytoclasia, or "nuclear dust"). Fibrin thrombi blocking the vessel lumen cause local ischemia, epidermal necrosis and painful erosions and ulcers.
Skin Findings in Cutaneous Necrotizing Venulitis (CNV)
| Clinical Finding | What the Lesions Look Like | Cellular and Molecular Mechanism |
|---|---|---|
| Palpable purpura | Deep red to purple papules or plaques concentrated on the lower third of the legs and ankles; they do not blanch on pressure and may itch or burn. | Red blood cells escape into the dermis through damaged vessel walls; bleeding plus inflammatory edema makes the papules raised. |
| Necrotic vesicles and bullae | Blood-filled blisters with a black or gray necrotic center that rupture easily, leaving painful erosions and ulcers. | Fibrin thrombi block the venules, causing acute local ischemia and necrosis of the epidermis. |
| Skin ulcers and necrotic scars | Ulcers with ragged edges, a dirty gray necrotic slough at the base and red, inflamed margins; they heal with atrophic or pigmented scars. | Excessive tissue breakdown by neutrophil enzymes and widespread cell death. |
| Urticarial vasculitis | Hive-like wheals that last more than 24 hours, burn or hurt more than they itch, and leave dark marks as they fade. | Milder immune complex deposition causes prolonged vascular leakage without complete vessel occlusion. |
| Systemic symptoms (variable) | Low-grade fever, joint pain, ankle swelling, fatigue, abdominal pain or blood in the urine (when internal organs are involved). | Release of inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) into the general circulation. |
Telling CNV Apart From Other Causes of Skin Bleeding
| Cutaneous Necrotizing Venulitis (CNV / LCV) | Immune Thrombocytopenic Purpura (ITP) | Pigmented Purpuric Dermatosis (Schamberg) |
|---|---|---|
| Raised papules that can be felt (palpable) | Flat (macular), cannot be felt | Flat, "cayenne pepper" dots |
| Often burning, aching or stinging | Completely painless and non-itchy | Usually asymptomatic or mildly itchy |
| Fibrinoid necrosis of vessel walls + neutrophil nuclear debris | Normal vessels, no vasculitis | Hemosiderin deposits, no fibrinoid necrosis |
| May have necrotic blisters and ulcers | Never causes skin necrosis or ulcers | No necrosis |
| Normal platelet count | Very low platelet count | Normal platelet count |
Our Approach
At Haute-Derma, patients with cutaneous necrotizing venulitis are assessed promptly and thoroughly to determine whether the disease is limited to the skin or part of a systemic process:
- Clinical screening and exposure history:
- A detailed review of all medications taken in the previous 2–4 weeks (beta-lactam antibiotics, NSAIDs, diuretics, anticonvulsants, etc.).
- Looking for a preceding infection (streptococcal infection, hepatitis B/C, HIV) or symptoms of autoimmune disease (joint pain, hair loss, dry eyes, kidney involvement).
- Confirmatory skin biopsy and direct immunofluorescence (DIF):
- Punch biopsy: taken from a fresh purpuric papule (12–48 hours old) to look for the gold-standard features: fibrinoid necrosis of the vessel wall, extravasated red blood cells and neutrophil nuclear dust (leukocytoclasia).
- Direct immunofluorescence (DIF): detects IgA deposits in the vessel walls (suggesting Henoch-Schönlein purpura / IgA vasculitis) or IgG/IgM/C3 deposits.
- Systemic screening:
- Complete blood count, erythrocyte sedimentation rate (ESR), CRP, liver and kidney function, and urinalysis (for blood and protein in the urine).
- Autoantibody testing: ANA, anti-dsDNA, ANCA (p-ANCA, c-ANCA), complement C3/C4, cryoglobulins, and hepatitis B/C serology.
Treatment Options at Haute-Derma
Treatment at Haute-Derma focuses on calming the acute vascular inflammation, removing the trigger and repairing necrotic skin damage:
- Removing the trigger and rest:
- All suspected culprit drugs must be stopped immediately.
- Patients are advised to keep their legs elevated when lying down and to wear compression stockings (once ulcers have healed) to lower hydrostatic pressure in the venules.
- Medical treatment to control acute inflammation:
- Mild or skin-limited disease: potent topical corticosteroids combined with an oral anti-inflammatory that modulates neutrophils, such as dapsone (50–100 mg/day) or colchicine (0.6–1.2 mg/day).
- Moderate to severe disease / extensive necrotic ulcers: a short course of oral corticosteroids (prednisolone 0.5–1 mg/kg/day) with gradual tapering. If internal organs are involved, the patient is co-managed with clinical immunology for stronger immunosuppressants (methotrexate, azathioprine, cyclophosphamide).
- Necrotic ulcer care and scar prevention at Haute-Derma:
- Ulcer cleansing and debridement: a gentle antiseptic solution combined with ultrasonic debridement or biological dressings containing fibrinolytic enzymes to clear the dirty gray necrotic slough without pain.
- Light therapy (phototherapy): red (630 nm) and near-infrared (830 nm) LED light to ease acute inflammatory pain, stimulate microcirculation and speed up wound healing.
- Skin restoration and scar treatment: once the ulcer has closed, medical silicone gel is applied and combined with fractional CO2 laser or microneedle RF to remodel the necrotic scar tissue into smoother skin.
